Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNITY HEALTH TORONTO currently manages a concentrated patent portfolio within the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action across the entire portfolio, indicating a very specific point of engagement with the patent office. This matter is handled by 1 distinct examiner, which reflects a narrow channel of prosecution for the company at this stage.
The prosecution activity is localized within 1 distinct art unit. This concentration suggests that the current legal challenges or examinations are confined to a specific technical niche within the broader sector. TRAN, CHAU NGUYEN BICH is identified as the busiest examiner for this portfolio, currently overseeing 1 pending office action in that capacity. Because this individual is responsible for the only active matter, the immediate outcome of the portfolio's prosecution rests entirely on this single interaction.
Practitioners should note that with only the current distinct examiner and art unit involved, there is no diversity in the examination perspectives currently being applied to the company's filings. A strategy focused on the pending office action is required to move the portfolio forward. This streamlined activity under TRAN, CHAU NGUYEN BICH allows for a very focused approach to resolving outstanding issues within the relevant domain.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, CHAU NGUYEN BICH | 1 | 31.6% | +45.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17763992 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE | TRAN, CHAU NGUYEN BICH | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17763992 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE | TRAN, CHAU NGUYEN BICH | 34d |
| Art Unit | Apps |
|---|---|
| 1677 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17763992 | COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE | TRAN, CHAU NGUYEN BICH | 1677 | §101§103§112 | Final Rejection | 34d | Pending | Mar 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial